CARDIA Study
CARDIA Study: Coronary Artery Risk Development In Young Adults (CARDIA). A study designed to increase understanding of contributors to changes in cardiovascular disease (CVD) risk factors during the critical years of transition from adolescence through young adulthood to middle age. CARDIA was funded by National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH).
The original objectives of CARDIA were to document levels of risk factors for coronary artery disease and potential determinants of these risk factors in young adults; to study the interrelationships of risk factors and lifestyles and to document behavioral and environmental changes during the transition from adolescence to middle age; to compare cross-sectional and longitudinal data on age-related trends in cardiovascular disease risk factors; and to compare levels and evolution of risk factors between men and women, blacks and whites, and in groups of differing socioeconomic status.
The goals of CARDIA have evolved to emphasize understanding determinants of left ventricular mass, emerging obesity and hypertension, and sequelae of hypertension in pregnancy. CARDIA is a population-based observational study of 5,115 black and white mena and women participants aged 18-30 years recruited in 1985-1986. The sample was designed to achieve approximately balanced subgroups of race, gender, education (high school or less and more than high school) and age (18-24 and 25-30). Forty percent of the cohort had no more than a high school education. A second examination (1987-1988), third (1990-1991), fourth (1992-1993), fifth (1995-1996), and sixth examinations (2000-2001) have been completed in the cohort.
In addition to standard measurements of blood pressure, anthropometry, blood lipids, smoking behavior, physical activity, diet, pulmonary function, and many psychological factors, CARDIA has other included measurements (in subsets or in the full cohort) to obtain unique information on other aspects of risk factor development and early morbidity. These have included: graded exercise treadmill testing; echocardiography, particularly for measurement of left ventricular mass; cardiovascular reactivity; serum cotinine; Lp(a), apoE phenotype, apolipoprotein A1 and B; homocysteine; skin reflectance; body composition by dual X-ray absorptiometry; glucose tolerance testing; vascular resistance and compliance; and plasma renin activity and sympathetic nervous system activity.
Read Also:
- Cardiac aneurysm
Cardiac aneurysm: An outpouching of an abnormally thin portion of the heart wall. Cardiac aneurysms tend to involve the left ventricle because the blood there is under the greatest pressure.
- Cardiac conduction system
Cardiac conduction system: The electrical conduction system that controls the heart rate. This system generates electrical impulses and conducts them throughout the muscle of the heart, stimulating the heart to contract and pump blood. Among the major elements in the cardiac conduction system are the sinus node, atrioventricular node, and the autonomic nervous system. The […]
- Cardiac defibrillator, implantable
Cardiac defibrillator, implantable: A device that is designed to be put in the body to recognize certain types of abnormal heart rhythms (arrhythmias) and correct them by delivering precisely calibrated and timed electrical shocks to restore a normal heartbeat. Defibrillators continuously monitor the heart rhythm in order to detect overly rapid life-threatening arrhythmias, such as […]
- Cardiac index
Cardiac index: A cardiodynamic measure based on the cardiac output, which is the amount of blood the left ventricle ejects into the systemic circulation in one minute, measured in liters per minute (l/min). Cardiac output is indexed to a patient’s body size by dividing by the body surface area to yield the cardiac index.
- Cardiac myocyte
Cardiac myocyte: A heart muscle cell. Sometimes called a myocyte when it is understood that it is in the heart. See also: Myocyte.